Targeting MYCN in Pediatric and Adult Cancers
The deregulation of the MYC family of oncogenes, including c-MYC, MYCN and MYCL occurs in many types of cancers, and is frequently associated with a poor prognosis. The majority of functional studies have focused on c-MYC due to its broad expression profile in human cancers. The existence of highly...
Main Authors: | Zhihui Liu, Samuel S. Chen, Saki Clarke, Veronica Veschi, Carol J. Thiele |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.623679/full |
Similar Items
-
Targeting MYCN in paediatric cancers
by: Arturo eSala
Published: (2015-05-01) -
Molecular Mechanisms of MYCN Dysregulation in Cancers
by: Ruochen Liu, et al.
Published: (2021-02-01) -
Reciprocal Induction of MDM2 and MYCN in Neural and Neuroendocrine Cancers
by: Hung N. Tran, et al.
Published: (2020-12-01) -
Perfil de expressão dos genes MYC, MYCN, TERT, ASPM e PRAME em Meduloblastoma
by: Vulcani-Freitas, Tânia Maria [UNIFESP]
Published: (2015) -
Targeting MYCN in Molecularly Defined Malignant Brain Tumors
by: Anna Borgenvik, et al.
Published: (2021-01-01)